Ada Rephaeli Selected Research

Ada Rephaeli Research Topics

Disease

33	Neoplasms (Cancer) 01/2022 - 11/2002
9	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2003
6	Glioblastoma (Glioblastoma Multiforme) 01/2018 - 09/2006
5	Cardiotoxicity 01/2021 - 04/2008
5	Carcinoma (Carcinomatosis) 01/2012 - 09/2006
4	Glioma (Gliomas) 03/2014 - 12/2005
4	Leukemia 05/2006 - 11/2002
3	Colonic Neoplasms (Colon Cancer) 06/2008 - 05/2003
2	Inflammation (Inflammations) 11/2021 - 02/2012
2	Poisoning 01/2021 - 01/2015
2	Hypoxia (Hypoxemia) 09/2020 - 02/2019
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2018 - 01/2016
2	Catalepsy 01/2009 - 05/2008
2	Prostatic Neoplasms (Prostate Cancer) 10/2007 - 08/2005
2	Neuroblastoma 01/2004 - 02/2003
2	Hematologic Neoplasms (Hematological Malignancy) 10/2003 - 11/2002
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022
1	Heart Failure 01/2021
1	Drug-Related Side Effects and Adverse Reactions 11/2019
1	Sickle Cell Anemia (Hemoglobin S Disease) 11/2019
1	Choroidal Neovascularization 02/2019
1	Corneal Neovascularization 07/2017
1	Anemia 08/2016
1	Mycosis Fungoides 01/2016
1	Sezary Syndrome (Sezary Erythroderma) 01/2016
1	Body Weight (Weight, Body) 03/2014
1	Necrosis 06/2012
1	Pain (Aches) 05/2009
1	Edema (Dropsy) 05/2009
1	Hyperalgesia 05/2009
1	Schizophrenia (Dementia Praecox) 01/2009

Drug/Important Bio-Agent (IBA)

24	ProdrugsIBA 01/2022 - 11/2002
18	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2021 - 11/2002
14	Histone Deacetylase InhibitorsIBA 11/2021 - 11/2002
13	Butyric Acid (Butanoic Acid)IBA 01/2018 - 11/2002
11	Formaldehyde (Formol)FDA Link 01/2022 - 02/2003
9	pivalyloxymethyl butyrateIBA 01/2008 - 11/2002
7	diethoxyphosphoryloxymethyl butanoateIBA 01/2018 - 08/2005
7	Pharmaceutical PreparationsIBA 01/2017 - 11/2002
6	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 05/2003
5	Proteins (Proteins, Gene)FDA Link 02/2019 - 01/2004
5	Antineoplastic Agents (Antineoplastics)IBA 03/2014 - 11/2002
4	DNA AdductsIBA 01/2022 - 01/2004
4	AcidsIBA 01/2017 - 02/2005
4	doxorubicin-DNAIBA 02/2010 - 02/2003
4	Butyrates (Butyrate)IBA 01/2008 - 11/2002
4	Histones (Histone)IBA 04/2007 - 08/2005
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 06/2012 - 12/2008
3	gamma-Aminobutyric Acid (GABA)IBA 05/2009 - 05/2008
3	EstersIBA 12/2008 - 09/2006
2	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2015 - 05/2006
2	AcetaldehydeIBA 06/2012 - 02/2005
2	AlaAcBuIBA 06/2012 - 12/2011
2	Antipsychotic Agents (Antipsychotics)IBA 01/2009 - 05/2008
2	Perphenazine (Trilafon)FDA LinkGeneric 01/2009 - 05/2008
2	Topoisomerase II InhibitorsIBA 04/2007 - 01/2005
2	AldehydesIBA 09/2006 - 02/2005
2	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2004 - 05/2003
1	AnthraquinonesIBA 01/2022
1	pixantrone (BBR 2778)IBA 01/2022
1	Oxygen (Dioxygen)IBA 11/2021
1	Valproic Acid (Depakote)FDA LinkGeneric 11/2021
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 09/2020
1	Hydroxyurea (Hydrea)FDA LinkGeneric 11/2019
1	Fetal Hemoglobin (Hemoglobin F)IBA 11/2019
1	Retinaldehyde (Retinal)IBA 02/2019
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2017
1	romidepsin (FK228)FDA Link 01/2016
1	Vorinostat FDA Link 01/2016
1	PoisonsIBA 01/2015
1	pivalic acidIBA 06/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2012
1	ABT-737IBA 02/2010
1	Carbon Nanotubes (Carbon Nanotube)IBA 02/2010
1	CytokinesIBA 05/2009
1	Nortriptyline (Aventyl)FDA LinkGeneric 05/2009
1	Antidepressive Agents (Antidepressants)IBA 05/2009
1	Fluoxetine (Prozac)FDA LinkGeneric 05/2009
1	CarrageenanIBA 05/2009
1	AmidesIBA 05/2009
1	Prolactin Receptors (Prolactin Receptor)IBA 01/2009
1	MicellesIBA 01/2009
1	Dopamine (Intropin)FDA LinkGeneric 01/2009
1	Amphetamine (Amfetamine)FDA LinkGeneric 01/2009
1	perphenazine GABA esterIBA 01/2009
1	Poloxamer (Poloxamer 407)IBA 01/2009
1	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2008
1	Heme (Haem)IBA 12/2008
1	Glutathione (Reduced Glutathione)IBA 08/2008
1	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2008
1	S-formylglutathioneIBA 08/2008
1	Biological ProductsIBA 06/2008
1	ProlactinIBA 05/2008
1	Fluphenazine (Prolixin)FDA LinkGeneric 05/2008
1	Dextroamphetamine (Dexedrine)FDA LinkGeneric 05/2008
1	sobuzoxaneIBA 04/2008

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 03/2014 - 11/2002
5	Therapeutics 06/2012 - 12/2005
2	Oral Administration 09/2006 - 08/2005
1	Photochemotherapy (Photodynamic Therapy) 12/2011